Combined Diffuse Astrocytoma and Pleomorphic Xanthoastrocytoma Grade III Sharing IDH1 R132H Mutation

被引:1
|
作者
Tourne, Morgan [1 ]
Tauziede-Espariat, Arnault [1 ]
Dezamis, Edouard [2 ]
Saffroy, Raphael [3 ]
Dhermain, Frederic [4 ]
Chretien, Fabrice [1 ]
Varlet, Pascale [1 ]
机构
[1] Descartes Univ, St Anne Hosp, Dept Neuropathol, Paris, France
[2] Descartes Univ, St Anne Hosp, Dept Neurosurg, Paris, France
[3] Hop Univ Paris Sud, Hop Paul Brousse, AP HP, Dept Biochem & Oncogenet, Villejuif, France
[4] Gustave Roussy Canc Campus, Dept Radiat Oncol, Villejuif, France
关键词
Anaplastic astrocytoma; BRAF V600E; Collision tumour; IDH1; mutation; Pleomorphic xanthoastrocytoma; COLLISION TUMOR; MENINGIOMA; DIFFERENTIATION; FEATURES; GLIOMAS; BRAIN;
D O I
10.1016/j.wneu.2018.05.156
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Collision tumors are often difficult to distinguish from intratumoral heterogeneity in diffuse gliomas. CASE DESCRIPTION: We report the case of a 44-year-old woman admitted for intracranial hypertension. Magnetic resonance imaging revealed a right intra-axial frontal mass, composed of a hypervascular nodular portion contrasting with a large nonenhanced infiltrative and muliticystic portion. Histopathologic examination showed the occurrence of two morphologically different gliomas. The largest component corresponded to an anaplastic astrocytoma, IDH1-mutated. The second corresponded to a leptomeningeal nodule, reminiscent of a pleomorphic xanthoastrocytoma. Both tumoral components exhibited anaplastic features, World Health Organization grade III. Immunohistochemical and molecular studies showed that the 2 components were identical, IDH1 R132H mutated but without BRAF V600E mutation. Tumor progression was assessed 2 years after surgery, after radiotherapy and chemotherapy, showing supratentorial leptomeningeal dissemination. CONCLUSIONS: Collision tumors and combined neoplasms have been rarely described in the brain and only 4 similar articles report the synchronous occurrence of 2 primary gliomas. A review of the literature is proposed, focusing on criteria that could be used to discriminate them.
引用
收藏
页码:316 / 321
页数:6
相关论文
共 50 条
  • [1] Combined "Infiltrating Astrocytoma/Pleomorphic Xanthoastrocytoma" Harboring IDH1 R132H and BRAF V600E Mutations
    Yamada, Seiji
    Kipp, Benjamin R.
    Voss, Jesse S.
    Giannini, Caterina
    Raghunathan, Aditya
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (02) : 279 - 284
  • [2] Monoclonal antibody specific for IDH1 R132H mutation
    Capper, David
    Zentgraf, Hanswalter
    Balss, Joerg
    Hartmann, Christian
    von Deimling, Andreas
    ACTA NEUROPATHOLOGICA, 2009, 118 (05) : 599 - 601
  • [3] C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma
    Avliyakulov, Nuraly K.
    Rajavel, Kavitha S.
    Le, Khanh Minh T.
    Guo, Lea
    Mirsadraei, Leili
    Yong, William H.
    Liau, Linda M.
    Li, Sichen
    Lai, Albert
    Nghiemphu, Phioanh L.
    Cloughesy, Timothy F.
    Linetsky, Michael
    Haykinson, Michael J.
    Pope, Whitney B.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 117 (01) : 53 - 65
  • [4] Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors
    Capper, David
    Weissert, Susanne
    Balss, Joerg
    Habel, Antje
    Meyer, Jochen
    Jaeger, Diana
    Ackermann, Ulrike
    Tessmer, Claudia
    Korshunov, Andrey
    Zentgraf, Hanswalter
    Hartmann, Christian
    von Deimling, Andreas
    BRAIN PATHOLOGY, 2010, 20 (01) : 245 - 254
  • [5] Somatic Mosaicism of IDH1 R132H Predisposes to Anaplastic Astrocytoma: A Case of Two Siblings
    Lee, Sulgi
    Kambhampati, Madhuri
    Almira-Suarez, M. Isabel
    Ho, Cheng-Ying
    Panditharatna, Eshini
    Berger, Seth, I
    Turner, Joyce
    Van Mater, David
    Kilburn, Lindsay
    Packer, Roger J.
    Myseros, John S.
    Vilain, Eric
    Nazarian, Javad
    Bornhorst, Miriam
    FRONTIERS IN ONCOLOGY, 2020, 9
  • [6] IDH1 R132H mutation is a rare event in myeloproliferative neoplasms as determined by a mutation specific antibody
    Andrulis, Mindaugas
    Capper, David
    Meyer, Jochen
    Penzel, Roland
    Hartmann, Christian
    Zentgraf, Hanswalter
    von Deimling, Andreas
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (10): : 1797 - 1798
  • [7] Detection of IDH1 R132H Mutation in Acute Myeloid Leukemia by Mutation-specific Immunohistochemistry
    Byers, Richard
    Hornick, Jason L.
    Tholouli, Eleni
    Kutok, Jeffery
    Rodig, Scott J.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (01) : 37 - 40
  • [8] IDH1 R132H Mutation Is Accompanied with Malignant Progression of Paired Primary-Recurrent Astrocytic Tumours
    Mu, Luyan
    Xu, Wanzhen
    Li, Qingla
    Ge, Haitao
    Bao, Hongbo
    Xia, Songsong
    Ji, Jingjing
    Jiang, Jie
    Song, Yuwen
    Gao, Qiang
    JOURNAL OF CANCER, 2017, 8 (14): : 2704 - 2712
  • [9] IDH1 R132H Decreases Proliferation of Glioma Cell Lines In Vitro and In Vivo
    Bralten, Linda B. C.
    Kloosterhof, Nanne K.
    Balvers, Rutger
    Sacchetti, Andrea
    Lapre, Lariesa
    Lamfers, Martine
    Leenstra, Sieger
    de Jonge, Hugo
    Kros, Johan M.
    Jansen, Erwin E. W.
    Struys, Eduard A.
    Jakobs, Cornelis
    Salomons, Gajja S.
    Diks, Sander H.
    Peppelenbosch, Maikel
    Kremer, Andreas
    Hoogenraad, Casper C.
    Smitt, Peter A. E. Sillevis
    French, Pim J.
    ANNALS OF NEUROLOGY, 2011, 69 (03) : 455 - 463
  • [10] Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
    Pellegatta, Serena
    Valletta, Lorella
    Corbetta, Cristina
    Patane, Monica
    Zucca, Ileana
    Sirtori, Federico Riccardi
    Bruzzone, Maria Grazia
    Fogliatto, Gianpaolo
    Isacchi, Antonella
    Pollo, Bianca
    Finocchiaro, Gaetano
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2015, 3 : 4